MARÍA ÁNGELES
VILLANÚA BERNUÉS
Investigadora hasta 2020
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (8)
2015
2011
-
Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy
American Journal of Physiology - Endocrinology and Metabolism, Vol. 300, Núm. 5
2000
-
Maternal exposure to the synthetic cannabinoid HU-210: Effects on the endocrine and immune systems of the adult male offspring
NeuroImmunoModulation, Vol. 7, Núm. 1, pp. 16-26
1998
-
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats
NeuroReport, Vol. 9, Núm. 15, pp. 3397-3402
-
Characterization of the acute endocrine actions of (-)-11-hydroxy-Δ8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats
European Journal of Pharmacology, Vol. 344, Núm. 1, pp. 77-86
1997
-
Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat
NeuroReport, Vol. 8, Núm. 2, pp. 491-496
1995
-
Cyclosporine Effects on in vitro Responsiveness of Anterior Pituitary Hormone Release to Dopamine and Thyrotropin‐Releasing Hormone in Young Female Rats
Journal of Neuroendocrinology, Vol. 7, Núm. 10, pp. 765-774
1989
-
Possible prolactin-mediated effects of melatonin on gonadotropin secretion in the rat
Pharmacology, Biochemistry and Behavior, Vol. 32, Núm. 1, pp. 157-162